Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel MCH antagonists covered by Schering-Plough patent

Aug. 26, 2002

In vitro and in vivo studies on bone-healing agent CP-533536 reported at ACS

Aug. 23, 2002

Bayer claims new thyroid-like compounds for lipoprotein disorders

Aug. 23, 2002

Novel 5-HT2C modulators prepared and tested at Roche and Vernalis

Aug. 23, 2002

Chromium picolinate improves carbohydrate and lipid metabolism in obese hyperinsulinemic rats

Aug. 23, 2002

Soybean phytosterols induce hypocholesterolemic effects in young adult men

Aug. 23, 2002

Treatment with statins reported not to be related to a higher risk for breast cancer

Aug. 23, 2002

Millennium reports SAR studies on melanocortin MC-4 antagonists

Aug. 22, 2002

Discovery of novel PPARalpha agonists and selection of a clinical candidate

Aug. 22, 2002

New hypolipidemic agents emerging from Aventis R&D

Aug. 21, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...